Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer.

MLA

Kobayashi, Kokoro, et al. “Impact of Immunohistological Subtypes on the Long-Term Prognosis of Patients with Metastatic Breast Cancer.” Surgery Today, vol. 46, no. 7, July 2016, pp. 821–26. EBSCOhost, https://doi.org/10.1007/s00595-015-1252-x.

APA

Kobayashi, K., Ito, Y., Matsuura, M., Fukada, I., Horii, R., Takahashi, S., Akiyama, F., Iwase, T., Hozumi, Y., Yasuda, Y., & Hatake, K. (2016). Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer. Surgery Today, 46(7), 821–826. https://doi.org/10.1007/s00595-015-1252-x

Chicago

Kobayashi, Kokoro, Yoshinori Ito, Masaaki Matsuura, Ippei Fukada, Rie Horii, Shunji Takahashi, Futoshi Akiyama, et al. 2016. “Impact of Immunohistological Subtypes on the Long-Term Prognosis of Patients with Metastatic Breast Cancer.” Surgery Today 46 (7): 821–26. doi:10.1007/s00595-015-1252-x.